美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

iShares Health Innovation Active ETF

34.41

-0.1816-0.53%

成交量：1,353

成交額：4.65萬

市值：1,376.20萬

市盈率：- -

高：34.41

開：34.24

低：34.24

收：34.59

52周最高：34.79

52周最低：25.79

股本：40.00萬

流通股本：40.00萬

量比：0.36

換手率：0.34%

股息：0.08

股息率：0.24%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

ANNOVIS BIO ：阿爾茨海默病3期臨床試驗已完成全部受試者入組；關鍵數據和申報預計將於2027年完成。

強生公司（JNJ）Imaavy獲FDA標籤擴展用於治療温性自身免疫溶血性貧血

石藥集團(01093)開發的重組呼吸道合胞病毒疫苗(SYS6057)在美國獲臨床試驗批准

石藥集團(01093.HK)開發的重組呼吸道合胞病毒疫苗(SYS6057)在美國獲臨床試驗批准

強生：IMAAVY獲FDA批准用於治療罕見血液疾病

美國食品和藥物管理局擴大了強生公司治療罕見血液疾病藥物的批准範圍

FDA批准Imaavy®成為温自身免疫性溶血性貧血（wAIHA）首創療法，為患者帶來里程碑式突破

REGENXBIO股價下跌24%，此前美國食品藥品監督管理局暫停了該公司針對亨特綜合徵的基因療法的臨床試驗。

衞材公司：Leqembi Iqlik（Lecanemab-Irmb）自動注射器現已在美國上市，用於早期阿爾茨海默病治療啓動

長風藥業(02652)：ICF001於獲國家藥監局臨床試驗默示許可後擴大適應症範圍

智通财经网

巴克萊因莫德納「具有變革性」的黑色素素瘤疫苗潛力上調其目標價

歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態

吉利德科學：歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌

寶濟藥業-B(02659)：KJ015注射液(抗HER2雙特異性抗體皮下製劑)臨床試驗申請獲得美國FDA許可

甘李藥業：GZC8072片獲准開展體重控制臨床試驗

mRNA疫苗點燃默沙東想象力「後K藥時代」找到新解法？

每日经济新闻

美股醫療板塊創6月以來最佳周表現，mRNA抗癌疫苗突破提振市場

三名科學家在涉及滑石粉研究的誹謗訴訟中勝訴，該訴訟由強生公司提起

受癌症疫苗試驗數據影響，Moderna股價連續第三個交易日劇烈震盪

默沙東(MRK.US)股價盤中上漲高達3.7%，突破周三創下的歷史高點。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/BMED/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":34.4051,"timestamp":1787601600000,"preClose":34.5867,"halted":0,"volume":1353,"delay":0,"changeRate":-0.0052505731972117345,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"盤前交易","change":-0.1816,"latestTime":"08-25 08:30:11 EDT","open":34.24,"high":34.4051,"low":34.24,"amount":46450,"amplitude":0.004774,"askPrice":55.04,"askSize":200,"bidPrice":13.77,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":34.4051,"sharesOutstanding":360000,"nav":34.566084000000004,"aum":13826433.6,"dividendRate":0.002401,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.27,"preClose":34.4051,"latestTime":"16:10 EDT","volume":6,"amount":206.4306,"timestamp":1787602204415,"change":-0.1351,"changeRate":-0.003927,"amplitude":0},"volumeRatio":0.3553046059869267,"impliedVol":0.3098,"impliedVolPercentile":0.792},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3553046059869267,"shares":400000,"dividePrice":0.0826,"high":34.4051,"amplitude":0.004774,"preClose":34.5867,"low":34.24,"week52Low":25.794,"pbRate":"--","week52High":34.7939,"institutionHeld":0,"latestPrice":34.4051,"eps":0,"divideRate":0.002401,"volume":1353,"delay":0,"ttmEps":0,"open":34.24,"prevYearClose":30.32,"prevWeekClose":34.5867,"prevMonthClose":30.9904,"prevQuarterClose":30.62,"fiveDayClose":32.4416,"twentyDayClose":30.7632,"sixtyDayClose":28.5717},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662340734","title":"ANNOVIS BIO ：阿爾茨海默病3期臨床試驗已完成全部受試者入組；關鍵數據和申報預計將於2027年完成。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662340734","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662340734?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 20:05","pubTimestamp":1787659504,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBJ","BMED","MDTX","BK4121","BIO","LU1169589451.USD","LU1169590202.USD","BK4585","IBBQ","PSYK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662073902","title":"強生公司（JNJ）Imaavy獲FDA標籤 擴展用於治療温性自身免疫溶血性貧血","url":"https://stock-news.laohu8.com/highlight/detail?id=2662073902","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662073902?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 19:17","pubTimestamp":1787656672,"startTime":"0","endTime":"0","summary":"FDA已于今年4月授予Imaavy该项适应症的优先审评资格，本次获批后Imaavy有望成为美国市场首款针对wAIHA的治疗药物。据相关统计，wAIHA发病率约为八千分之一，发病机理为机体自身抗体破坏红细胞，进而引发贫血症状。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210625/YzM5OTgzZmE3NTA3Njg3Nzc4Mjg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM5OTgzZmE3NTA3Njg3Nzc4Mjg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305283","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1914381329.SGD","GDOC","IE00B2B36J28.USD","LU2756315664.SGD","LABU","LU2430703251.USD","BK4534","LU0345769631.USD","LU0820561909.HKD","RXL","FHLC","PJP","LU0795875169.SGD","LU0964807845.USD","BK4504","XLV","TRUH","IYH","LU2347655156.SGD","BK4007","LU0820561818.USD","IE00B19Z3B42.SGD","LU1629891620.HKD","FTXH","MEDX","VHT","JDOC","LU0162691827.USD","LU0210536198.USD","IE000SO60NU8.SGD","IE00BFTCPJ56.SGD","LU0787776722.HKD","LU1585245621.USD","IHE","SG9999001176.SGD","BMED","IE00BJJMRZ35.SGD","IE00BBT3K403.USD","IE00BN8TJ469.HKD","LU2456880835.USD","JNJ","LU1221951046.USD","LU2505996681.GBP","LU2602419157.SGD","LU0234572021.USD","IE00B3PB1722.GBP","IE00BZ1G4Q59.USD","IE00BLSP4452.SGD","LU2750360997.AUD","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662978739","title":"石藥集團(01093)開發的重組呼吸道合胞病毒疫苗(SYS6057)在美國獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2662978739","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662978739?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 19:15","pubTimestamp":1787656512,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 公布，集团开发的预防用生物制品1类新药重组呼吸道合胞病毒疫苗已获得美国食品药品监督管理局批准，可在美国开展临床试验。该产品为该集团第二款获批临床试验的重组蛋白疫苗产品，由呼吸道合胞病毒融合前F蛋白抗原与集团自主研发的第二代纳米佐剂体系组成。本次获批的临床适应症为用于60岁及以上人群预防RSV引起的下呼吸道疾病。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0326950275.SGD","LU1993786604.SGD","BK1191","159646","HK0000165453.HKD","IE0008369823.USD","LU1328277881.USD","MDTX","01093","LU1813983027.USD","KURE","IE00B031HY20.USD","LU0072913022.USD","PSYK","LU0140636845.USD","IBBQ","IE0008368742.USD","LU1226288170.HKD","LU0880133367.SGD","BK1515","IE00B543WZ88.USD","LU1807302812.USD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","LU2039709279.SGD","IE00BZ08YR35.GBP","IBBJ","LU0501845795.SGD","LU1226288253.USD","SG9999004220.SGD","LU1152091168.USD","IE00B5MMRT66.SGD","LU1226287792.SGD","LU0067412154.USD","LU0315179316.USD","LU1226287875.USD","LU0314109678.HKD","BK1521","LU1951186391.HKD","LU1152091754.HKD","LU1226287529.USD","LU1008478684.HKD","BMED","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662073994","title":"石藥集團(01093.HK)開發的重組呼吸道合胞病毒疫苗(SYS6057)在美國獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2662073994","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662073994?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 19:15","pubTimestamp":1787656512,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PSYK","IBBJ","MDTX","IBBQ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662204777","title":"強生：IMAAVY獲FDA批准用於治療罕見血液疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=2662204777","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662204777?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 08:18","pubTimestamp":1787617106,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0640476718.USD","BMED","IE00BJT1NW94.SGD","IE0009355771.USD","LU2487616109.SGD","LU1267930813.SGD","BK4533","MEDX","LU1228905540.USD","LU1674673691.USD","BK4588","LU1196500208.SGD","LABU","IHE","LU0203345920.USD","IE000SO60NU8.SGD","LU1629891620.HKD","BK4592","BK4568","LU0985320562.USD","LU2505996509.AUD","IXJ","JNJ","BK4532","LU1989771016.USD","LU2468319806.SGD","FHLC","LU0072461881.USD","LU0320765646.SGD","LU1718418525.SGD","LU0466842654.USD","IYH","GDOC","FTXH","SGXZ57979304.SGD","LU1066053197.SGD","SG9999001176.SGD","JDOC","TRUH","XLV","IE0034235303.USD","PJP","LU1228905037.USD","IE0002270589.USD","LU0820562030.AUD","LU2896262040.SGD","LU2403377893.USD","RXL","VHT","LU2129689514.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662720191","title":"美國食品和藥物管理局擴大了強生公司治療罕見血液疾病藥物的批准範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2662720191","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662720191?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 06:32","pubTimestamp":1787610737,"startTime":"0","endTime":"0","summary":"美国食品和药物管理局扩大了强生公司治疗罕见血液疾病药物的批准范围路透8月24日-强生公司周一表示，美国食品和药物管理局已批准扩大其药物JNJ.N的适应症，用于治疗一种罕见血液疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4T44L1IL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2456880835.USD","LU1778281490.HKD","BK4581","LU0882574055.USD","FHLC","LU1061106388.HKD","IE00B19Z3B42.SGD","LU0787776722.HKD","IE00BVYPNW00.USD","LU2417539215.USD","LU2471134879.HKD","LU1989771016.USD","FTXH","IE00BBT3K403.USD","BK4585","TRUH","MEDX","LU2505996681.GBP","JDOC","LU0426417589.USD","IE00BSNM7G36.USD","IE0034235303.USD","BK4534","LU1894683264.USD","SG9999002232.USD","PJP","IE0002141913.USD","LU1032955483.USD","LU1145028129.USD","LU2487616109.SGD","BK4588","IHE","BMED","IXJ","LU0345769631.USD","LU1221951129.SGD","VHT","GDOC","BK4504","LU0345769128.USD","LU1228905540.USD","LU2236285917.USD","LU0640476718.USD","LU0289739699.SGD","XLV","LU1551013342.USD","IYH","RXL","JNJ","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155022349","title":"FDA批准Imaavy®成為温自身免疫性溶血性貧血（wAIHA）首創療法，為患者帶來里程碑式突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1155022349","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155022349?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 06:31","pubTimestamp":1787610685,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局正式批准Imaavy上市，这是首个针对温自身免疫性溶血性贫血的治疗药物，标志着该疾病领域迎来历史性转折。这一批准不仅填补了治疗空白，更为长期缺乏有效方案的患者开辟了全新路径。此项决定源自严格的临床评估，Imaavy的疗效与安全性获得充分验证。如今，Imaavy的问世，有望重塑治疗格局，提升患者生活质量，降低疾病复发风险。wAIHA作为一种罕见病，其治疗困境长期未解，而此药的上市，无疑为患者群体注入了强心剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689514.USD","LU2456880835.USD","BMED","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU0795875169.SGD","BK4559","IYH","LU0234570918.USD","LU1430594728.SGD","PJP","IE00BLSP4239.USD","GDOC","SG9999002224.SGD","LU0289739699.SGD","IHE","LU0792757196.USD","LU0882574055.USD","LU2487616109.SGD","LU1935042991.SGD","XLV","LU0426412945.USD","LU1043141123.HKD","LU1221951046.USD","SGXZ80539844.SGD","LU2417539215.USD","BK4568","LU0124676726.USD","LU1032466523.USD","LU0203345920.USD","LU0234572021.USD","LU1674673428.USD","JDOC","MEDX","LU1894683348.USD","JNJ","VHT","LU2471134952.CNY","IE000BZT7R73.USD","LU0820561818.USD","LU2129689605.HKD","IE00BVYPNV92.GBP","LU2756315664.SGD","SG9999013999.USD","IE00BDGV0183.EUR","IE000M9KFDE8.USD","BK4504","LU0426417589.USD","IE00BBT3K403.USD","IXJ","LU1032955483.USD","LU1778281490.HKD","LU2213496289.HKD","IE00B42XCP33.USD","IE00BGHQF631.EUR","BK4592","SG9999002232.USD","LU0912757837.SGD","BK4588","LU1043141396.HKD","LU1196500208.SGD","LU2112291526.USD","BK4533","LU1074936037.SGD","IE00B7SZLL34.SGD","LU0683600562.USD","IE00BLSP4452.SGD","LU1732800096.USD","SGXZ57979304.SGD","LU1066051225.USD","LU0889566641.SGD","LU1244550577.SGD","IE000MB6IJN5.SGD","IE000F7OJYX1.SGD","LU1506573853.SGD","LU1629891620.HKD","LU1989771016.USD","LU0122379950.USD","IE00BZ1G4Q59.USD","LU2430703095.HKD","LU1061106388.HKD","LU0203347892.USD","IE00BJT1NW94.SGD","LU2471134796.USD","LU1057294990.SGD","SG9999001440.SGD","LU1059921491.USD","LU1162221912.USD","LU1291159041.SGD","SG9999001176.SGD","LU0345770993.USD","IE000SO60NU8.SGD","LU2471134879.HKD","LU1280957306.USD","LU2592432038.USD","LU0795875086.SGD","LU1718418525.SGD","IE0002270589.USD","IE00B1BXHZ80.USD","LU0070217475.USD","LU2129689431.USD","IE00BN8TJ469.HKD","LU0210536198.USD","LU0640476718.USD","LU1674673691.USD","LU1066053197.SGD","LU0058720904.USD","IE00BJJMRZ35.SGD","LU1228905037.USD","LU0820562030.AUD","LU2023250330.USD","IE00BFXG1179.USD","LU1585245621.USD","BK4534","LU1496350502.SGD","BK4581","IE00BFTCPJ56.SGD","LU1221951129.SGD","BK4550","IE00BSNM7G36.USD","LU0787776722.HKD","LU1244550494.USD","LU2133065610.SGD","LU2505996509.AUD","IE00B3T34201.USD","LU2430703251.USD","LU1983299246.USD","IE000WAW04H5.SGD","LU2403377893.USD","LU2471134523.USD","FTXH","IE00B3PB1722.GBP","LU0053666078.USD","LU0320765646.SGD","LU1914381329.SGD","LU2430703178.SGD","IE0002141913.USD","IE00B19Z3581.USD","LU2089984988.USD","LU1066051811.HKD","LU2505996681.GBP","IE0009355771.USD","LU1244550221.USD","LU1261432733.SGD","LU2750360997.AUD","LU1551013342.USD","LU0689626769.HKD","LU1732799900.SGD","IE00B2B36J28.USD","LU0964807845.USD","LU1894683264.USD","LU2756315318.SGD","LU1228905540.USD","LU1023059063.AUD","LU0072461881.USD","LU0994945656.USD","FHLC","LU0210528500.USD","LU0943347566.SGD","IE00BVYPNW00.USD","IE0034235303.USD","LU1145028129.USD","LU2347655156.SGD","LU0689472784.USD","BK4585","BK4007","IE00B4R5TH58.HKD","LU0820561909.HKD","LU1121112475.USD","LU1551013425.SGD","BK4532","RXL","IE0001KFT4U8.USD","SG9999001176.USD","LU2602419157.SGD","LU0114720955.EUR","LU0432979614.USD","LU0345769631.USD","LU2896262040.SGD","LU0098860793.USD","LU0985320562.USD","LU2236285917.USD","LU1267930813.SGD","LU0466842654.USD","LU0162691827.USD","IE0000B7K699.USD","LU1066051498.USD","LU2468319806.SGD","LU1929549753.HKD","LU0345769128.USD","LU2750360641.GBP","LU0345770308.USD","TRUH","LU0545562505.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271420","title":"REGENXBIO股價下跌24%，此前美國食品藥品監督管理局暫停了該公司針對亨特綜合徵的基因療法的臨床試驗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271420","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271420?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 21:32","pubTimestamp":1787578348,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","IBBJ","IBBQ","PSYK","CNCR","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169385922","title":"衞材公司：Leqembi Iqlik（Lecanemab-Irmb）自動注射器現已在美國上市，用於早期阿爾茨海默病治療啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=1169385922","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169385922?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 20:04","pubTimestamp":1787573051,"startTime":"0","endTime":"0","summary":"卫材株式会社宣布，其用于启动早期阿尔茨海默病治疗的Leqembi Iqlik自动注射器，现已正式登陆美国市场。与传统的静脉输注方式相比，这款自动注射器的问世，无疑为治疗流程的优化开辟了新的路径。随着该产品在美国的落地，早期阿尔茨海默病患者及其家庭或将迎来更为主动、可控的疾病管理体验。市场观察人士认为，这一创新给药方式的引入，或将对现有治疗格局产生积极而深远的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9Z06.USD","PBE","BK4588","BMED","IE00B894F039.SGD","LU0889565916.HKD","IE00B19Z9P08.USD","LU0234570918.USD","BK4585","BK4139","LU0109394709.USD","BK4532","BK4533","LU0320765992.SGD","BIIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661756722","title":"長風藥業(02652)：ICF001於獲國家藥監局臨床試驗默示許可後擴大適應症範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2661756722","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661756722?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:37","pubTimestamp":1787571455,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业 发布公告，集团自主研发的长效吸入干粉候选药物ICF001已获中华人民共和国国家药品监督管理局就间质性肺病开展临床试验的临床试验默示许可。上述许可乃继该产品于2026年3月就肺动脉高压及间质性肺病相关肺高压取得国家药监局临床试验默示许可之后取得。该产品现已获准就涵盖肺血管疾病及进行性纤维化肺病的四项适应症开展临床研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BMED","PSYK","02652","IBBJ","IBBQ","BK1191","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273989","title":"巴克萊因莫德納「具有變革性」的黑色素素瘤疫苗潛力上調其目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273989","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273989?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:05","pubTimestamp":1787569505,"startTime":"0","endTime":"0","summary":"BUZZ-巴克莱因莫德纳“具有变革性”的黑色素素瘤疫苗潜力上调其目标价8月24日-** 巴克莱将疫苗制造商莫德纳（MRNA.O）的目标价从48美元上调至125美元，维持“中性”评级** 新目标价较该股上周五收盘价仍有13.9%的下行空间** 此次上调目标价发生在莫德纳和默克公司MRK.N联合宣布其共同开发的皮肤癌疫苗晚期临床试验取得 (link) 突破性成果一周之后，该试验表明，实验性疗法Inti","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4S44L0RI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494708.USD","LU1116320901.HKD","MRNA","IE00B4R5TH58.HKD","LU1066051811.HKD","LU1201861249.SGD","BK4534","LU1291159041.SGD","LU1989771016.USD","XLV","LU2106854487.HKD","IDNA","LU2023250504.SGD","MRNY","LU2023250843.SGD","IE0002141913.USD","LU1066051498.USD","SGXZ57979304.SGD","LU0965509101.SGD","SG9999014542.SGD","LU1929549753.HKD","LU0122379950.USD","LU1934455277.USD","BK4585","IE00BJJMRZ35.SGD","LU0985320562.USD","LU0265550359.USD","FTXH","LU2491050071.SGD","LU2089984988.USD","LU1941712348.USD","LU1923622614.USD","SG9999014575.USD","LU2361045086.USD","LU2360032135.SGD","BK4548","SG9999001176.SGD","LU0238689110.USD","LU0266013472.USD","WDNA","BK4533","SG9999014559.SGD","LU0006306889.USD","PPH","SG9999015341.SGD","LU0965509283.SGD","LU1989772923.USD","LU1934455863.HKD","LU0868494617.USD","LU2491049909.HKD","VHT","IYH","BK4588","GDOC","LU2112291526.USD","BK4559","LU1037948897.HKD","LU0689626769.HKD","LU0106261372.USD","HRTS","IE00BSNM7G36.USD","LU1983299246.USD","BK4139","LU0823416689.USD","LU1066051225.USD","LU2125154778.USD","IE00B2B36J28.USD","LU0265550946.USD","LU1430594728.SGD","IE000M9KFDE8.USD","LU0648001328.SGD","LU1699723380.USD","LU1917777945.USD","LU2357627491.SGD","LU0208291251.USD","LU0432979614.USD","BK4501","LU1037948541.HKD","SG9999015358.SGD","GNOM","LU1066053197.SGD","LU2125909593.SGD","FHLC","MRNX","LU0130517989.USD","LU0861579265.USD","LU1069347547.HKD","LU2461242641.AUD","LU0203345920.USD","LU1989772840.SGD","SG9999014567.USD","LU1023059063.AUD","LU1934455194.USD","SG9999001440.SGD","IHE","LU1585245621.USD","LU1974910355.USD","SG9999002232.USD","LU0477156953.USD","BK4516","IE00B1BXHZ80.USD","LU1057294990.SGD","BK4550","IE00BLSP4239.USD","LU0203347892.USD","PAWZ","BK4007","SG9999001176.USD","BK4568","LU0320765489.SGD","LU1093756325.SGD","LU2361044865.SGD","BK4532","LU0070302665.USD","IE0009355771.USD","LU0980610538.SGD","JDOC","LU0211331839.USD","IXJ","LU0859254822.USD","LU0320765646.SGD","LU0965509010.AUD","LU1571399168.USD","LGHT","LU1941712264.USD","LU0289739699.SGD","LU2125909247.SGD","LU1093756168.USD","IE00BJT1NW94.SGD","LU2324357040.USD","LU2468319806.SGD","LU0098860793.USD","LU0130102774.USD","BMED","LU2491050154.USD","BK4551","LU1116320737.USD","SG9999002224.SGD","IE00BLSP4452.SGD","LU1035773651.USD","LU0965508806.USD","LU2125154935.USD","LU2361044949.HKD","LU0058720904.USD","LU0234572021.USD","IE00BFTCPJ56.SGD","LU1162221912.USD","RXL","IE00BBT3K403.USD","LU0124676726.USD","MRK","LU2433249047.HKD","LU1061106388.HKD","IE00BN8TJ469.HKD","SG9999013999.USD","LU0942090050.USD","TRUH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186632498","title":"歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態","url":"https://stock-news.laohu8.com/highlight/detail?id=1186632498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186632498?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567559,"startTime":"0","endTime":"0","summary":"欧盟委员会近日作出重要决定，将吉利德科学（Gilead Sciences）旗下重磅药物Trodelvy®的适用范围进一步拓宽。此次调整聚焦于转移性三阴性乳腺癌的一线治疗领域，且不再受限于患者的PD-L1表达状态。这一举措意味着，无论生物标志物检测结果如何，符合条件的患者均有望从该疗法中获益。此举不仅为临床医生提供了更为灵活的用药选择，也标志着Trodelvy®在肿瘤治疗版图中的地位得到显著提升。吉利德科学方面对此表示积极回应，认为该批准将助力满足更多患者未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU0965508806.USD","LU2089984988.USD","LU2468319806.SGD","LU0320765992.SGD","LU0114720955.EUR","LU1023059063.AUD","TBXU","LU1057294990.SGD","IE00B19Z3581.USD","IBB","SG9999015986.USD","SG9999015945.SGD","LU2112291526.USD","BK4566","LU1674673428.USD","BK4532","LU1037948541.HKD","LU0109394709.USD","LU0234570918.USD","LU1934455194.USD","LU1061106388.HKD","LU1066051498.USD","IE00B3T34201.USD","LU1934455863.HKD","IE00BKVL7J92.USD","BK4568","GILD","LU0122379950.USD","BK4583","LU0965509010.AUD","LU0058720904.USD","LU2357627491.SGD","BK4585","IBBQ","LU2324357040.USD","LU0965509283.SGD","BK4588","LU1430594728.SGD","LU2087621335.USD","SG9999015978.USD","LU1585245621.USD","BK4578","BMED","BBH","LU0823416689.USD","LU0889565916.HKD","MEDI","LU1778281490.HKD","IE0002270589.USD","LU0882574055.USD","LU1839511570.USD","LU0861579265.USD","LU0289739699.SGD","IE00BZ1G4Q59.USD","LU1037948897.HKD","LU1066053197.SGD","LU1571399168.USD","LU1934455277.USD","SG9999015952.SGD","TMED","LU0965509101.SGD","BK4139","LU1674673691.USD","IE00B19Z3B42.SGD","LU0859254822.USD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193380081","title":"吉利德科學：歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1193380081","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193380081?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567533,"startTime":"0","endTime":"0","summary":"吉利德科学公司宣布，欧盟已正式授予其抗体药物偶联物Trodelvy与默沙东的Keytruda联合用药方案的上市许可。这一批准针对的是既往未经治疗的PD-L1阳性转移性三阴性乳腺癌患者群体。此项授权标志着该联合疗法在欧盟地区的临床可及性迈出关键一步，为这类侵袭性强、治疗选择有限的乳腺癌亚型患者提供了新的一线治疗选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","LU0861579265.USD","LU0965508806.USD","LU1057294990.SGD","LU1066051498.USD","LU1778281490.HKD","LU0965509283.SGD","SG9999015952.SGD","BK4550","BK4585","LU1571399168.USD","LU2112291526.USD","LU1037948897.HKD","LU2357627491.SGD","LU0109394709.USD","LU1839511570.USD","TMED","IE00B3T34201.USD","BMED","BIB","LU1585245621.USD","LU0859254822.USD","BK4568","GILD","IE00B7SZLL34.SGD","IBBQ","LU0289739699.SGD","LU1037948541.HKD","BK4566","LU1674673691.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","TBXU","BBH","LU0234570918.USD","LU2089984988.USD","LU2087621335.USD","LU1061106388.HKD","LU1430594728.SGD","IE00BKVL7J92.USD","LU1066053197.SGD","LU0823416689.USD","LU1934455194.USD","BK4583","LU0965509010.AUD","IE0002270589.USD","LU0058720904.USD","BK4588","LU0882574055.USD","IE00B19Z3581.USD","SG9999015945.SGD","LU0889565916.HKD","LU2324357040.USD","IE00BZ1G4Q59.USD","LU1674673428.USD","LU1934455277.USD","LU1023059063.AUD","LU1934455863.HKD","BK4139","IE00BSNM7G36.USD","LU0122379950.USD","SG9999015986.USD","LU0114720955.EUR","SG9999015978.USD","BK4532","LU2468319806.SGD","BK4578","LU0965509101.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661095227","title":"寶濟藥業-B(02659)：KJ015注射液(抗HER2雙特異性抗體皮下製劑)臨床試驗申請獲得美國FDA許可","url":"https://stock-news.laohu8.com/highlight/detail?id=2661095227","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661095227?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:02","pubTimestamp":1787565773,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宝济药业-B 发布公告，于2026年8月21日，本公司自主研发的KJ015注射液的新药临床试验申请获得美国食品药品监督管理局批准，获准在美国开展临床试验。本公司的临床前研究显示，KJ015相较于传统抗HER2单克隆抗体组合，在临床前阶段的整体疗效有所增强。本公司正内部开发KJ015，并拥有开发及商业化KJ015的全球权利。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","PSYK","IBBJ","02659","BMED","IBBQ","BK1161","LABU","BK4588","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661467224","title":"甘李藥業：GZC8072片獲准開展體重控制臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2661467224","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661467224?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 17:04","pubTimestamp":1787562270,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDTX","IBBJ","IBBQ","PSYK","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661243397","title":"mRNA疫苗點燃默沙東想象力 「後K藥時代」找到新解法？","url":"https://stock-news.laohu8.com/highlight/detail?id=2661243397","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661243397?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 20:39","pubTimestamp":1787488796,"startTime":"0","endTime":"0","summary":"疫苗公司Moderna（莫德纳）和美国药企默沙东宣布黑色素瘤皮肤癌疫苗IntismeranAutogene（以下简称intismeran）在大型试验中达到目标影响。资本市场反应强烈。莫德纳当日股价大涨近177%，默沙东同步大涨近13%，整个mRNA（信使核糖核酸）板块也随之出现明显行情。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608233850380834.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608233850380834.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2360032135.SGD","SG9999002224.SGD","LU1037948541.HKD","LU1116320737.USD","FTXH","LU2491049909.HKD","LU2491050154.USD","LU2361045086.USD","LU0234572021.USD","BK4139","IE00B1BXHZ80.USD","IE00BN8TJ469.HKD","FHLC","IE00BBT3K403.USD","LU2023250843.SGD","IE00BLSP4239.USD","MRNX","BK4559","SG9999001176.SGD","BK4585","IE000M9KFDE8.USD","BK4588","LU2125909247.SGD","PPH","LU0289739699.SGD","LU0320765489.SGD","LU1093756168.USD","LU0208291251.USD","PAWZ","BK4568","LU0130517989.USD","LU2125154935.USD","LU1057294990.SGD","BK4551","LU0058720904.USD","SG9999015358.SGD","MRNA","LU0211331839.USD","LU2433249047.HKD","LU0203347892.USD","LU2112291526.USD","LU2089984988.USD","LU1699723380.USD","LU2361044865.SGD","LU0098860793.USD","LU1116320901.HKD","LU1585245621.USD","LU0689626769.HKD","GDOC","SG9999014559.SGD","TRUH","LU0265550946.USD","LU0124676726.USD","LU1061106388.HKD","IXJ","LU1989772840.SGD","LU1917777945.USD","WDNA","IE00B2B36J28.USD","LU1934455277.USD","LU1066053197.SGD","LU2461242641.AUD","SGXZ57979304.SGD","BK4534","LU0868494617.USD","SG9999014567.USD","LU1989772923.USD","SG9999014542.SGD","SG9999015341.SGD","SG9999001176.USD","LU1201861249.SGD","LU2106854487.HKD","LU0265550359.USD","LU1934455194.USD","LU0070302665.USD","BK4548","LU1430594728.SGD","LU0477156953.USD","LU0861579265.USD","LU1983299246.USD","SG9999013999.USD","LU1023059063.AUD","LU0965509283.SGD","IE00B4R5TH58.HKD","LU0823416689.USD","BK4533","LU2125909593.SGD","LU2324357040.USD","LU0980610538.SGD","BMED","IHE","LU0965509101.SGD","GNOM","LU1069347547.HKD","LU1941712348.USD","IE00BLSP4452.SGD","LU1934455863.HKD","IE0002141913.USD","LU1974910355.USD","RXL","LU0965508806.USD","LU1037948897.HKD","LU1066051225.USD","BK4550","IDNA","LU0859254822.USD","LU1291159041.SGD","LU1923622614.USD","LU0122379950.USD","LU1571399168.USD","LU0238689110.USD","LGHT","LU2357627491.SGD","LU0432979614.USD","HRTS","LU2361044949.HKD","LU2023250504.SGD","LU0006306889.USD","BK4007","BK4532","LU1989771016.USD","LU0203345920.USD","IE0009355771.USD","LU0266013472.USD","LU0985320562.USD","VHT","SG9999001440.SGD","MRK","LU0648001328.SGD","LU2491050071.SGD","LU1093756325.SGD","LU0106261372.USD","MRNY","IYH","LU1035773651.USD","LU0130102774.USD","LU0965509010.AUD","LU2125154778.USD","LU2468319806.SGD","SG9999002232.USD","BK4501","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0320765646.SGD","LU1929549753.HKD","SG9999014575.USD","XLV","LU1941712264.USD","IE00BSNM7G36.USD","LU1066051811.HKD","LU1066051498.USD","LU0868494708.USD","LU1162221912.USD","IE00BJT1NW94.SGD","LU0942090050.USD","JDOC","BK4516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661057292","title":"美股醫療板塊創6月以來最佳周表現，mRNA抗癌疫苗突破提振市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2661057292","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661057292?lang=zh_tw&edition=fundamental","pubTime":"2026-08-22 03:49","pubTimestamp":1787341783,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4533","LU0980610538.SGD","FTXH","HRTS","IE00BJJMRZ35.SGD","LU1035773651.USD","GDOC","IHE","SG9999015341.SGD","LU0203347892.USD","JDOC","LU2125154778.USD","PAWZ","LU1162221912.USD","LU1066053197.SGD","LU0130102774.USD","LU1974910355.USD","LU1093756325.SGD","LU0648001328.SGD","LU1066051498.USD","MRK","LU2357627491.SGD","LU0320765646.SGD","LU1093756168.USD","LU0689626769.HKD","LU2125154935.USD","VHT","FHLC","LU0058720904.USD","XLV","LU2360032135.SGD","LU1571399168.USD","IXJ","LU1037948897.HKD","LU2468319806.SGD","LU2023250504.SGD","IE00B4R5TH58.HKD","LU1934455277.USD","LU1941712264.USD","LU0234572021.USD","LU2361045086.USD","BMED","LU1941712348.USD","IE00BLSP4239.USD","TRUH","IYH","LU0098860793.USD","LU1116320737.USD","PPH","RXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661917672","title":"三名科學家在涉及滑石粉研究的誹謗訴訟中勝訴，該訴訟由強生公司提起","url":"https://stock-news.laohu8.com/highlight/detail?id=2661917672","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661917672?lang=zh_tw&edition=fundamental","pubTime":"2026-08-22 00:28","pubTimestamp":1787329711,"startTime":"0","endTime":"0","summary":"三名科学家在涉及滑石粉研究的诽谤诉讼中胜诉，该诉讼由强生公司提起Dietrich Knauth路透纽约8月21日-弗吉尼亚州的一位美国法官裁定，三名研究人员发表的研究将化妆品级滑石粉产品与间皮瘤联系起来，此举并不构成对强生公司的诽谤。三名被告均为从事病理学诊疗工作的医生，曾作为原告方专家在石棉诉讼中出庭作证。强生公司还起诉了发表2019年论文的科学家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL4T44I0ZO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000F7OJYX1.SGD","GDOC","IE00BBT3K403.USD","FTXH","IE00BSNM7G36.USD","LU0426412945.USD","IE00B3T34201.USD","LU0432979614.USD","LU1121112475.USD","LU1551013425.SGD","BK4550","IE00BVYPNV92.GBP","SGXZ57979304.SGD","JDOC","BK4007","LU0689472784.USD","LU0689626769.HKD","LU1228905037.USD","JNJ","IE0002270589.USD","LU0964807845.USD","LU0345769128.USD","FHLC","LU1989771016.USD","LU2471134879.HKD","IYH","VHT","IE0000B7K699.USD","BMED","LU2487616109.SGD","LU2602419157.SGD","LU1145028129.USD","LU1894683264.USD","PJP","LU2468319806.SGD","RXL","LU2129689514.USD","LU0426417589.USD","LU2456880835.USD","MEDX","LU2430703095.HKD","LU1983299246.USD","IXJ","LU1894683348.USD","TRUH","LU1032466523.USD","XLV","LU1732800096.USD","IHE","LU1043141396.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661229152","title":"受癌症疫苗試驗數據影響，Moderna股價連續第三個交易日劇烈震盪","url":"https://stock-news.laohu8.com/highlight/detail?id=2661229152","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661229152?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 23:58","pubTimestamp":1787327905,"startTime":"0","endTime":"0","summary":"BUZZ-受癌症疫苗试验数据影响，Moderna股价连续第三个交易日剧烈震荡8月21日-** 莫德纳（Moderna）MRNA.O股价上涨14.5%，至152.60美元，收复了周四部分跌幅** 周五的反弹标志着受莫德纳和默克MRK.N周三公布的晚期癌症疫苗临床试验数据 (link) 影响，股价已连续第三个交易日出现剧烈波动** 周三，Moderna股价暴涨近177% (link)，周四则暴跌23.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL4S44I0Y8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","LU1983299246.USD","LU0098860793.USD","LU0432979614.USD","IDNA","LU0648001328.SGD","LU1069347547.HKD","LU2357627491.SGD","XLV","LU1430594728.SGD","LU0320765646.SGD","LU1037948897.HKD","LU1917777945.USD","LU1585245621.USD","SG9999015341.SGD","LU1934455277.USD","LU1162221912.USD","LU1699723380.USD","LU1035773651.USD","LU2125909593.SGD","SG9999002224.SGD","LU0965509101.SGD","LU0689626769.HKD","LU1066051498.USD","GNOM","JDOC","IXJ","MRNY","LU0124676726.USD","LU0985320562.USD","LU0289739699.SGD","LU0122379950.USD","HRTS","LU0320765489.SGD","LU1934455863.HKD","LU1116320901.HKD","SG9999014542.SGD","IE00B2B36J28.USD","LU2491050071.SGD","LU0265550946.USD","FTXH","IE00B1BXHZ80.USD","RXL","LU0266013472.USD","LU0106261372.USD","LU0965508806.USD","LU2106854487.HKD","LU0130517989.USD","LU0203347892.USD","IYH","LU2491049909.HKD","LU2461242641.AUD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU1066051811.HKD","LU1571399168.USD","BMED","LU0477156953.USD","SG9999001176.USD","LU1116320737.USD","SG9999015358.SGD","BK4585","IE0002141913.USD","IE00BJT1NW94.SGD","LU1066051225.USD","LU1934455194.USD","PPH","LU0868494617.USD","LU0965509283.SGD","MRK","LU1929549753.HKD","BK4532","LU2468319806.SGD","PAWZ","BK4533","TRUH","LU1989771016.USD","BK4568","LU2491050154.USD","BK4534","BK4551","LU1974910355.USD","MRNX","LU0965509010.AUD","LU1989772923.USD","LU1923622614.USD","SG9999013999.USD","IE000M9KFDE8.USD","IE00BSNM7G36.USD","LU2361044949.HKD","SG9999001440.SGD","LU1989772840.SGD","FHLC","LU0238689110.USD","BK4007","LU1941712264.USD","LU2433249047.HKD","BK4550","SG9999002232.USD","IE00BLSP4239.USD","LU0203345920.USD","LU1057294990.SGD","LU2125154935.USD","LU0211331839.USD","IHE","BK4559","LU1201861249.SGD","LU2112291526.USD","BK4588","LU1093756325.SGD","LU1941712348.USD","SG9999001176.SGD","BK4548","LU2089984988.USD","LU0070302665.USD","IE0009355771.USD","GDOC","IE00BBT3K403.USD","LU0859254822.USD","LU1037948541.HKD","WDNA","BK4139","IE00BN8TJ469.HKD","LU2361045086.USD","LU0058720904.USD","LU0823416689.USD","SGXZ57979304.SGD","LGHT","LU0265550359.USD","LU2360032135.SGD","LU2125909247.SGD","BK4516","IE00BFTCPJ56.SGD","BK4501","LU2324357040.USD","LU0868494708.USD","MRNA","IE00B4R5TH58.HKD","LU1093756168.USD","LU1291159041.SGD","LU2125154778.USD","IE00BLSP4452.SGD","LU0980610538.SGD","LU0234572021.USD","LU2023250504.SGD","LU2023250843.SGD","LU2361044865.SGD","LU0861579265.USD","LU1061106388.HKD","SG9999014575.USD","LU0208291251.USD","LU0130102774.USD","SG9999014567.USD","LU0006306889.USD","LU0942090050.USD","VHT","SG9999014559.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661729698","title":"默沙東(MRK.US)股價盤中上漲高達3.7%，突破周三創下的歷史高點。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661729698","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661729698?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 22:28","pubTimestamp":1787322483,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4007","LU1571399168.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0965509101.SGD","IE00BSNM7G36.USD","LU1093756168.USD","LU0289739699.SGD","LU2023250504.SGD","LU1023059063.AUD","SG9999001176.SGD","LU0234572021.USD","LU1934455194.USD","LU0208291251.USD","IE000M9KFDE8.USD","LU0477156953.USD","LU1291159041.SGD","VHT","LU2125154935.USD","LU0320765489.SGD","LU0965509283.SGD","FTXH","BK4533","LU2112291526.USD","IE00BJT1NW94.SGD","TRUH","LU0203345920.USD","LU2433249047.HKD","LU0868494708.USD","JDOC","LU0432979614.USD","BK4550","SG9999013999.USD","SG9999015358.SGD","LU0265550359.USD","LU1116320737.USD","IE00BN8TJ469.HKD","LU1974910355.USD","LU0203347892.USD","LU1066051225.USD","BK4559","LU2360032135.SGD","LU1066051498.USD","SG9999015341.SGD","HRTS","LU1430594728.SGD","IE00BBT3K403.USD","LU0238689110.USD","LU0965509010.AUD","LU2491050071.SGD","XLV","LU1066051811.HKD","LU2491050154.USD","LU0861579265.USD","IE00B1BXHZ80.USD","IE00BFTCPJ56.SGD","LU1066053197.SGD","LU1941712264.USD","LU0859254822.USD","LU0942090050.USD","LU0266013472.USD","LU1201861249.SGD","LU2125909593.SGD","LU0648001328.SGD","LU1069347547.HKD","LU1983299246.USD","SG9999002232.USD","LU0070302665.USD","LU1699723380.USD","LU0130102774.USD","IE00BLSP4452.SGD","LU1162221912.USD","LU1093756325.SGD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU1035773651.USD","LU1989772840.SGD","RXL","PPH","LU1037948897.HKD","LU0689626769.HKD","GDOC","LU1989772923.USD","LU1934455863.HKD","LU2106854487.HKD","LU0868494617.USD","LU0965508806.USD","SG9999014542.SGD","LU2324357040.USD","LU1934455277.USD","IYH","LU2361044865.SGD","LU2361045086.USD","LU0980610538.SGD","LU0985320562.USD","IE00B2B36J28.USD","LU0006306889.USD","BMED","SG9999001440.SGD","LU0823416689.USD","BK4516","LU0098860793.USD","LU1917777945.USD","LU0122379950.USD","LU0211331839.USD","LU2089984988.USD","SG9999014575.USD","LU2361044949.HKD","BK4534","LU0265550946.USD","IE0009355771.USD","BK4588","LU1057294990.SGD","LU1989771016.USD","LU2023250843.SGD","LU1061106388.HKD","LU2125909247.SGD","SG9999002224.SGD","BK4585","LU1941712348.USD","LU1037948541.HKD","LU2357627491.SGD","LU2125154778.USD","SG9999001176.USD","LU2461242641.AUD","IE00BLSP4239.USD","LU0058720904.USD","PAWZ","LU1116320901.HKD","LU0320765646.SGD","LU0130517989.USD","SGXZ57979304.SGD","LU1929549753.HKD","IHE","IXJ","LU2491049909.HKD","LU0106261372.USD","LU0124676726.USD","FHLC","SG9999014567.USD","LU1585245621.USD","LU1923622614.USD","SG9999014559.SGD","MRK"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}